Fibroblast growth factor 21 enhances angiogenesis and wound healing of human brain microvascular endothelial cells by activating PPARγ

被引:48
作者
Huang, Wenting [1 ]
Shao, Mingjie [1 ]
Liu, Huan [2 ]
Chen, Jun [2 ]
Hu, Jian [2 ]
Zhu, Liyun [2 ]
Liu, Fei [2 ]
Wang, Dongxue [2 ]
Zou, Yuchi [3 ]
Xiong, Ye [3 ]
Wang, Xue [1 ,2 ]
机构
[1] Wenzhou Med Univ, Sch Clin Med Sci 1, Wenzhou 325035, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325035, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou 315020, Zhejiang, Peoples R China
关键词
Angiogenesis; Wound healing; FGF21; FGF21/FGFR1/beta-klotho complex; PPAR gamma; IN-VITRO; MECHANISMS; PATHWAY; DISEASE;
D O I
10.1016/j.jphs.2019.03.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Angiogenesis of brain microvascular endothelial cells (BMECs) is required in the functional restoration of brain injury, such as traumatic brain injury (TBI) and ischemic stroke. Fibroblast growth factor 21 (FGF21) is an angiogenic molecule that functions through the formation of the FGF21/FGFR1/beta-klotho complex but does not cause carcinogenic events. The current study was to determine whether recombinant human FGF21 (rhFGF21) could promote angiogenesis and scratch wound healing of human brain microvascular endothelial cells (HBMECs) and the possible underlying mechanism. rhFGF21 promoted angiogenesis and migration of HBMECs. The FGFR1 inhibitor PD173074 was applied to demonstrate that rhFGF21 functions through the formation of FGF21/FGFR1/beta-klotho complexes. In addition, the specific PPAR gamma inhibitor GW9662 and PPAR gamma activator rosiglitazone were applied to determine that the role of rhFGF21 in increasing angiogenesis is through the PPAR gamma pathway. In addition, we revealed that the effect of rhFGF21 acts partially through upregulating eNOS expression. In conclusion, our study provides novel evidence that rhFGF21 can enhance the angiogenesis and migration of HBMECs through the formation of the FGF21/FGFR1/beta-klotho complex via PPAR gamma activation and eNOS upregulation, indicating that FGF21 is a potential therapeutic angiogenic agent for the treatment of human brain injury. (C) 2019 The Authors. Production and hosting by Elsevier B. V. on behalf of Japanese Pharmacological Society.
引用
收藏
页码:120 / 127
页数:8
相关论文
共 29 条
[11]   Identification of a novel FGF, FGF-21, preferentially expressed in the liver [J].
Nishimura, T ;
Nakatake, Y ;
Konishi, M ;
Itoh, N .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2000, 1492 (01) :203-206
[12]   Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis [J].
Norton, Kerri-Ann ;
Popel, Aleksander S. .
SCIENTIFIC REPORTS, 2016, 6
[13]   PPARs: A Potential Target for a Disease-Modifying Strategy in Stroke [J].
Ouk, Thavarak ;
Potey, Camille ;
Gautier, Sophie ;
Bastide, Michele ;
Deplanque, Dominique ;
Staels, Bart ;
Duriez, Patrick ;
Leys, Didier ;
Bordet, Regis .
CURRENT DRUG TARGETS, 2013, 14 (07) :752-767
[14]  
Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO
[15]  
2-3
[16]   Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2 [J].
Presta, Marco ;
Foglio, Eleonora ;
Schuind, Ander Churruca ;
Ronca, Roberto .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[17]   Vasculogenesis, angiogenesis, and arteriogenesis: Mechanisms of blood vessel formation and remodeling [J].
Semenza, Gregg L. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 102 (04) :840-847
[18]   Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation [J].
Villapol, Sonia .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2018, 38 (01) :121-132
[19]   Osthole inhibits pancreatic cancer progression by directly exerting negative effects on cancer cells and attenuating tumor-infiltrating M2 macrophages [J].
Wang, Botao ;
Zheng, Xin ;
Liu, Jing ;
Zhang, Zhen ;
Qiu, Chongyang ;
Yang, Lei ;
Zhang, Lanqiu ;
Zhang, Qi ;
Gao, Hongwei ;
Wang, Ximo .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2018, 137 (03) :290-298
[20]  
Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298